Brightstar Associates LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:30 pm Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Brightstar Associates LLC | 23,059,708 28.200% |
-48,136 (-0.21%) |
Filing |
| 2023-02-08 4:16 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Brightstar Associates LLC | 23,107,844 28.200% |
6,535,474 (+39.44%) |
Filing |